Skip to content

13F-HR filed by ISZO CAPITAL MANAGEMENT LP

ISZO CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 7 holding rows worth $190,109,000.

Accession
0001567619-22-004398
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 7 entries on the cover page, a total value of $190,109,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $190,109,000 with VALUE read as thousands by filing date, 13F file number 028-16140. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVID BIOSERVICES INC05368M106COM2,208,313$64,439,000thousands by filing date
INOTIV INC45783Q100COM1,275,379$53,655,000thousands by filing date
NAM TAI PROPERTY INCG63907102Com6,673,362$37,946,000thousands by filing date
LIFECOREBIOMEDICALINC514766104STOK1,925,311$21,371,000thousands by filing date
XPEL INC98379L100COM103,860$7,092,000thousands by filing date
CRYO-CELL INTL INC228895108COM482,931$5,602,000thousands by filing date
GLOBAL CORD BLOOD CORPG39342103COM1,000$4,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-004398this filing2022-02-14acceptance time not in the bulk data set